ConductScience.org, home

Paper41368010

Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.

Yeoh DK and 17 others. Lancet Reg Health West Pac, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps. Papers, record 41368010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41368010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.
PubMed
Journal
Lancet Reg Health West Pac
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-12-12
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yeoh DKDaniel K
2Boast AAlison
3Wen SCSophie Ch
4Williams PCPhoebe Cm
5Voss LLesley
6Ritchie BBrett
7Mostaghim MMona
8Lutui FFlora
9Lei AAlice
10Lai TTony
11Irwin ADAdam D
12Harwood KKiera
13Ewin TThomas
14Cooper CCelia
15Best EEmma
16Bannister SSarah
17Gwee AAmanda
18KIDS DOSE groupGroup

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131122767Hard to study, hard to treat: putting children at the centre of antibiotic research and development.Lancet Infect Dis2019https://conductscience.org/library/papers/31122767PubMed
233603583Extended Infusion of Beta-Lactams Is Associated With Improved Outcomes in Pediatric Patients.J Pediatr Pharmacol Ther2021https://conductscience.org/library/papers/33603583PubMed
322249106Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.Clin Ther2012https://conductscience.org/library/papers/22249106PubMed
437190910A multicentre, retrospective audit of fosfomycin use for urinary tract infections in Australian children and adolescents.J Antimicrob Chemother2023https://conductscience.org/library/papers/37190910PubMed
539165021
Australian Group on Antimicrobial Resistance surveillance outcome programs - bloodstream infections and antimicrobial resistance patterns from patients less than 18 years of age, January 2020 - December 2021.
Commun Dis Intell (2018)2024https://conductscience.org/library/papers/39165021PubMed
627503642Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27503642PubMed
732349993Antimicrobial resistance in the Pacific Island countries and territories.BMJ Glob Health2020https://conductscience.org/library/papers/32349993PubMed
828011614Dosing guidance for intravenous colistin in critically-ill patients.Clin Infect Dis2017https://conductscience.org/library/papers/28011614PubMed
920585118Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20585118PubMed
1034051403Compassionate use of cefiderocol for VIM metallo-β-lactamase-producing Pseudomonas aeruginosa infection in a toddler with Burkitt lymphoma.J Glob Antimicrob Resist2021https://conductscience.org/library/papers/34051403PubMed
1133313656Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections.Clin Infect Dis2021https://conductscience.org/library/papers/33313656PubMed
1238516290The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019-2022.Lancet Reg Health West Pac2024https://conductscience.org/library/papers/38516290PubMed
1331192975Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis.Pediatr Infect Dis J2019https://conductscience.org/library/papers/31192975PubMed
1434687548Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and Older.Clin Pharmacol Ther2022https://conductscience.org/library/papers/34687548PubMed
1522354300In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22354300PubMed
1635349496Infections Due to Antibiotic-resistant Gram-negative Bacteria in Pediatrics: Possible Management Strategies.Pediatr Infect Dis J2022https://conductscience.org/library/papers/35349496PubMed
1735078765Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload.Arch Dis Child2022https://conductscience.org/library/papers/35078765PubMed
1838648808Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics.Lancet Child Adolesc Health2024https://conductscience.org/library/papers/38648808PubMed
1935065702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed
2038917034Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes.Clin Infect Dis2024https://conductscience.org/library/papers/38917034PubMed

See all 91 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42538347Influence of probiotics on faecal antibiotic resistome in neonates: a systematic review.Pediatr Res2026https://conductscience.org/library/papers/42538347PubMed
42529261Comparative analysis of virulence and resistance gene profiles between carbapenem-resistant and ESBL-producing Escherichia coli.Front Microbiol2026https://conductscience.org/library/papers/42529261PubMed
41933301Risk factors for carbapenem-resistant Acinetobacter baumannii infection in children and A. baumannii-related mortality in the PICU: a retrospective study in Guangxi, China.BMC Infect Dis2026https://conductscience.org/library/papers/41933301PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41368010

GET https://conductscience.org/api/papers/v1/41368010/references?page=2